Auto-Injectors Market Growing Demand and Growth Opportunity & Forecast

1

Auto-Injectors Market Growth Trends, Key Players,
Competitive Strategies and Forecasts to 2026
FMI Report with Expert Review

• April 2021

Report Id     REP-GB-1642 Published On  
2017-03-06Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Auto-Injectors Market Analysis
Prefilled auto-injectors segment anticipated to
contribute to the highest growth opportunity due
to growing demand for intramuscular drug delivery
in the global auto-injectors market Auto-injector
s are pen like devices used to deliver a fixed
dose of drug to patients and are intended for
self-administration. Auto-injectors are gradually
becoming the gold-standard in the treatment of
various indications like anaphylaxis, multiple
sclerosis, rheumatoid arthritis and others. Most
of the auto-injectors are spring loaded, and the
procedure is relatively simple. These are
specialised instruments that can be used to avoid
needle stick injury and reduce needle phobia
among patients. In 1990, the first reusable
auto-injector, known as Imigran was launched for
the treatment of migraine. Auto-injector
manufacturers are focussed on user centric design
approaches to enhance ease-of-use and overcome
the unwillingness associated with
self-administration of intramuscular
injections. Auto-Injectors are expected to
present vast opportunities to investors due to
high demand in biologics development. Overall
revenues from the pre-filled syringes segment is
expected to grow during the forecast period due
to the rising need for targeted and sustained
drug delivery. In September 2015, Bayer
Healthcare reported the launch of Betaconnect
the only electronic auto-injector for the
treatment of relapsing-remitting multiple
sclerosis (RRMS). 
5
Auto-Injectors Market Analysis
The procedure does not require a visit to
hospitals, clinics, etc. and reduces dependency
on healthcare professionals, which is why
auto-injectors are becoming a choice of therapy
for patients suffering from anaphylaxis, multiple
sclerosis, rheumatoid arthritis and others.
Increasing adoption of auto-injectors due to
benefits such as increased safety, accuracy and
minimal discomfort is expected to fuel market
revenue growth over the forecast
period. The global auto-injectors market was
valued at nearly US 1700 Mn in 2016. The market
is anticipated to exhibit a CAGR of 15.1 during
the forecast period and is projected to be valued
at nearly US 7,000 Mn by the end of 2026. Get a
Sample of this Research Report https//www.future
marketinsights.com/reports/sample/rep-gb-1642 Glo
bal Auto-Injectors Market Analysis Forecast, By
Indication, 20162026 Anaphylaxis segment
dominated the global auto-injectors market by
indication in terms of revenue in 2015 and the
trend is projected to sustain throughout the
forecast period. Anaphylaxis segment is the most
attractive segment with an attractiveness index
of 3.55 over the forecast period.
6
Auto-Injectors Market Analysis
evenue from the anaphylaxis segment is
anticipated to register a CAGR of 15 over
20162026, to reach more than US 6,000 Mn by
2026. Multiple sclerosis segment is expected to
be the second most lucrative segment in the
global auto-injectors market by indication, with
an attractiveness index of 0.2 during the
forecast period. Multiple sclerosis segment
accounted for 5.3 value share in 2016 and is
projected to account for 5.5 share by 2026
end. Global trend Reduction in reliance on
healthcare provisions due to auto-injectors Auto-
injectors are economical as they reduce about 95
of primary healthcare costs, as there is no need
to attend clinics and hospitals for the
administration of the injection by healthcare
professionals. Auto-injectors provide inexpensive
home medication and reduce the time consumed at
in-patient and out-patient care units. For
patients requiring frequent dose administration
weekly and daily, the use of auto-injectors
reduces the average cost per injection. In
addition, auto-injectors reduce needle-stick
injuries. Reduction in dependence on healthcare
professionals is boosting the use of
auto-injectors and is likely to increase the
revenue growth of the market over the forecast
period.
7
Auto-Injectors Market Analysis
Key players in the global auto-injectors
market Some key players in the global
auto-injectors market included in this report are
Becton, Dickinson and Company, Sanofi, Pfizer,
Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen
Global Services, LLC, Antares Pharma, Inc., Amgen
Inc. and Eli Lilly and Company. Mylan N.V. is a
leader in the global auto-injectors market in
terms of revenue share. Mylan holds a market
share of about 83.7 in the global auto-injectors
market owing to the fact that the blockbuster
product Epipen is a widely sold auto-injector
and has a tremendous contribution to the global
auto-injectors market. Becton, Dickinson and
Company is one of the leading manufacturers of
refillable auto-injectors focussing on
manufacturing Physioject that is compatible with
several injectable drugs. In terms of revenue,
Becton, Dickinson and Company holds about 8.4 of
the global auto-injectors market share owing to a
rising adoption of Physioject. Browse Download
Report ToC https//www.futuremarketinsights.com/r
eports/auto-injectors-market/toc
8
Auto-Injectors Market Analysis
Analysts Viewpoint Reduction in price due to
approved generic versions will boost the sales
revenue of global auto injector devices over the
forecast period Drop in price of Epipen from US
600 to US 300 Auto-injectors manufacturers are
introducing generic versions in order to reduce
the overall cost of the device. To better serve
anaphylaxis patients with epinephrine at an
affordable cost, Mylan N.V. has implemented the
decision to introduce the generic version of
Epipen at half the price. The initial pack of two
was sold at US 600 till December 2016 which will
be sold at US 300 from January 2017. This has
increased the affordability of insured as well as
non-insured patients to opt for Epipen. This drop
in price will increase the penetration of the
EpiPen auto-injector, which holds around 90
share of the overall market. Request for
Report Methodology https//www.futuremarketinsigh
ts.com/askus/rep-gb-1642
9
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)